PG
BNTX icon

Pendal Group’s BioNTech BNTX Stock Holding History

Pendal Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,957,594
Closed -$334M – 463
2022
Q1 		$334M Buy
1,957,594
+1,654
+0.1% +$278K 2.75% 8
2021
Q4 		$504M Buy
1,955,940
+500,115
+34% +$137M 4.04% 5
2021
Q3 		$397M Buy
+1,455,825
New +$463M 3.28% 6

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Pendal Group's BNTX Position: Q2 2022 in Review

Pendal Group sold out of BioNTech (BNTX) in Q2 2022, closing a stake of 1,957,594 shares — an estimated $334M sold.

Pendal Group first reported a position in BNTX in Q3 2021 and held it in 3 quarters. The position peaked at $504M in Q4 2021. 293 funds tracked by Wall St. Rank hold BNTX as of Q2 2022.

  • Pendal Group reported no remaining BioNTech position as of Q2 2022 after selling out during the quarter.
  • Pendal Group sold 1,957,594 BioNTech shares in Q2 2022, an estimated $334M.
  • Pendal Group first reported a position in BioNTech in Q3 2021 and held it in 3 quarters.
  • Pendal Group's BioNTech position peaked at $504M in Q4 2021.
  • 293 funds tracked by Wall St. Rank held BioNTech as of Q2 2022.

Based on Pendal Group's 13F filing for Q2 2022, filed 25 Jul 2022.